Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental allergic asthma

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 5756-5763

  Mushaben, Elizabeth M ^a,b   Kramer, Elizabeth L ^a,b   Brandt, Eric B ^a,b   Khurana Hershey, Gurjit K ^a,b   Le Cras, Timothy D ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; PEPTIDOLEUKOTRIENE; RAPAMYCIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL METAPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL COUNT; FEMALE; GOBLET CELL; MACROPHAGE; METAPLASIA; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ASTHMA; BLOTTING, WESTERN; BRONCHIAL HYPERREACTIVITY; CELL SEPARATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GOBLET CELLS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; PYROGLYPHIDAE; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 82755187679     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102133     Document Type: Article

References (46)

1. Bateman, E. D., S. S. Hurd, P. J. Barnes, J. Bousquet, J. M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S. E. Pedersen, et al. 2008. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31: 143-178.
2. Hesselmar, B., B. Aberg, B. Eriksson, and N. Aberg. 2000. Asthma in children: prevalence, treatment, and sensitization. Pediatr. Allergy Immunol. 11: 74-79. (Pubitemid 30352835)
3. Masoli, M., D. Fabian, S. Holt, R. Beasley; Global Initiative for Asthma (GINA) Program. 2004. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478. (Pubitemid 38580764)
4. Hamid, Q., and M. Tulic. 2009. Immunobiology of asthma. Annu. Rev. Physiol. 71: 489-507.
5. Holgate, S. T. 2008. Pathogenesis of asthma. Clin. Exp. Allergy 38: 872-897.
6. Sehgal, S. N. 2003. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant. Proc. 35(3, Suppl.)7S-14S. (Pubitemid 36547910)
7. Vézina, C., A. Kudelski, and S. N. Sehgal. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. (Tokyo) 28: 721-726.
8. Reiling, J. H., and D. M. Sabatini. 2006. Stress and mTORture signaling. Oncogene 25: 6373-6383. (Pubitemid 44582282)
9. Laplante, M., and D. M. Sabatini. 2009. mTOR signaling at a glance. J. Cell Sci. 122: 3589-3594.
10. Sarbassov, D. D., S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley, A. L. Markhard, and D. M. Sabatini. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22: 159-168.
11. Powell, J. D., and G. M. Delgoffe. 2010. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33: 301-311.
12. Tsang, C. K., H. Qi, L. F. Liu, and X. F. Zheng. 2007. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov. Today 12: 112-124. (Pubitemid 46176669)
13. Guertin, D. A., and D. M. Sabatini. 2007. Defining the role of mTOR in cancer. Cancer Cell 12: 9-22. (Pubitemid 47001784)
14. Saunders, R. N., M. S. Metcalfe, and M. L. Nicholson. 2001. Rapamycin in transplantation: a review of the evidence. Kidney Int. 59: 3-16. (Pubitemid 32055209)
15. Säemann, M. D., M. Haidinger, M. Hecking, W. H. Hörl, and T. Weichhart. 2009. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am. J. Transplant. 9: 2655-2661.
16. Eynott, P. R., M. Salmon, T. J. Huang, T. Oates, P. L. Nicklin, and K. F. Chung. 2003. Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats. Immunology 109: 461-467. (Pubitemid 36783273)
17. Fujitani, Y., and A. Trifilieff. 2003. In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am. J. Respir. Crit. Care Med. 167: 193-198. (Pubitemid 36076079)
18. Nagai, H., Y. Maeda, and H. Tanaka. 1997. The effect of anti-IL-4 monoclonal antibody, rapamycin and interferon-gamma on airway hyperreactivity to acetylcholine in mice. Clin. Exp. Allergy 27: 218-224. (Pubitemid 27085424)
19. Kramer, E. L., E. M. Mushaben, P. A. Pastura, T. H. Acciani, G. H. Deutsch, G. K. Khurana Hershey, T. R. Korfhagen, W. D. Hardie, J. A. Whitsett, and T. D. Le Cras. 2009. Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am. J. Respir. Cell Mol. Biol. 41: 415-425.
20. Zhang, X., I. P. Lewkowich, G. Köhl, J. R. Clark, M. Wills-Karp, and J. Köhl. 2009. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells. J. Immunol. 182: 5123-5130.
21. Le Cras, T. D., T. H. Acciani, E. M. Mushaben, E. L. Kramer, P. A. Pastura, W. D. Hardie, T. R. Korfhagen, U. Sivaprasad, M. Ericksen, A. M. Gibson, et al. 2011. Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L414-L421.
22. Leverkoehne, I., and A. D. Gruber. 2002. The murine mCLCA3 (alias gob-5) protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J. Histochem. Cytochem. 50: 829-838 (Pubitemid 34721451)
23. Haley, K. J., and J. M. Drazen. 1998. Inflammation and airway function in asthma: what you see is not necessarily what you get. Am. J. Respir. Crit. Care Med. 157: 1-3.
24. Crimi, E., A. Spanevello, M. Neri, P. W. Ind, G. A. Rossi, and V. Brusasco. 1998. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157: 4-9. (Pubitemid 28071253)
25. Denzler, K. L., M. T. Borchers, J. R. Crosby, G. Cieslewicz, E. M. Hines, J. P. Justice, S. A. Cormier, K. A. Lindenberger, W. Song, W. Wu, et al. 2001. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J. Immunol. 167: 1672-1682. (Pubitemid 32703170)
26. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779. (Pubitemid 39249645)
27. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776. (Pubitemid 39249644)
28. Siegle, J. S., N. Hansbro, C. Herbert, M. Yang, P. S. Foster, and R. K. Kumar. 2006. Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am. J. Respir. Cell Mol. Biol. 35: 565-570. (Pubitemid 44706429)
29. Gessner, A., K. Mohrs, and M. Mohrs. 2005. Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J. Immunol. 174: 1063-1072. (Pubitemid 40094303)
30. Kim, M. S., H. S. Kuehn, D. D. Metcalfe, and A. M. Gilfillan. 2008. Activation and function of the mTORC1 pathway in mast cells. J. Immunol. 180: 4586-4595.
31. Jung, U., J. E. Foley, A. A. Erdmann, Y. Toda, T. Borenstein, J. Mariotti, and D. H. Fowler. 2006. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. Biol. Blood Marrow Transplant. 12: 905-918.
32. Barrett, N. A., and K. F. Austen. 2009. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 31: 425-437.
33. Finkelman, F. D., S. P. Hogan, G. K. Hershey, M. E. Rothenberg, and M. Wills-Karp. 2010. Importance of cytokines in murine allergic airway disease and human asthma. J. Immunol. 184: 1663-1674.
34. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erle. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8: 885-889.
35. Montuschi, P., A. Sala, S. E. Dahlén, and G. Folco. 2007. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Discov. Today 12: 404-412. (Pubitemid 46636374)
36. Vargaftig, B. B., and M. Singer. 2003. Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L260-L269. (Pubitemid 36164360)
37. Halayko, A. J., S. Kartha, G. L. Stelmack, J. McConville, J. Tam, B. Camoretti-Mercado, S. M. Forsythe, M. B. Hershenson, and J. Solway. 2004. Phophatidylinositol- 3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation. Am. J. Respir. Cell Mol. Biol. 31: 266-275. (Pubitemid 39180295)
38. Dumont, F. J., M. J. Staruch, S. L. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144: 251-258. (Pubitemid 20030485)
39. Delgoffe, G. M., T. P. Kole, Y. Zheng, P. E. Zarek, K. L. Matthews, B. Xiao, P. F. Worley, S. C. Kozma, and J. D. Powell. 2009. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
40. Liu, G., K. Yang, S. Burns, S. Shrestha, and H. Chi. 2010. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat. Immunol. 11: 1047-1056.
41. Battaglia, M., A. Stabilini, and M. G. Roncarolo. 2005. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748.
42. Kang, J., S. J. Huddleston, J. M. Fraser, and A. Khoruts. 2008. De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J. Leukoc. Biol. 83: 1230-1239. (Pubitemid 351960355)
43. Strauss, L., T. L. Whiteside, A. Knights, C. Bergmann, A. Knuth, and A. Zippelius. 2007. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J. Immunol. 178: 320-329. (Pubitemid 46033615)
44. Valmori, D., V. Tosello, N. E. Souleimanian, E. Godefroy, L. Scotto, Y. Wang, and M. Ayyoub. 2006. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J. Immunol. 177: 944-949. (Pubitemid 44036595)
45. Bousquet, J., P. Cabrera, N. Berkman, R. Buhl, S. Holgate, S. Wenzel, H. Fox, S. Hedgecock, M. Blogg, and G. D. Cioppa. 2005. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60: 302-308. (Pubitemid 40293345)
46. D'Amato, G., A. Salzillo, A. Piccolo, M. D'Amato, and G. Liccardi. 2007. A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma. Ther. Clin. Risk Manag. 3: 613-619. (Pubitemid 47496966)